rabeprazole has been researched along with z 338 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamizu, T; Futagami, S; Gudis, K; Hashimoto, S; Iwakiri, K; Kawagoe, T; Kodaka, Y; Maruki, Y; Nagoya, H; Sakamoto, C; Sato, H; Yamawaki, H | 1 |
| Harada, S; Higashino, T; Higuchi, K; Hoshimoto, M; Itabashi, T; Kawaguchi, S; Kojima, K; Kojima, Y; Kuramoto, T; Kusano, M; Ota, K; Sakaguchi, M; Sakamoto, H; Sanomura, M; Takada, K; Takahashi, Y; Takeuchi, T; Tominaga, K | 1 |
| Agawa, S; Futagami, S; Gudis, K; Higuchi, K; Iwakiri, K; Kaneko, K; Kawamoto, C; Kodaka, Y; Murakami, M; Sakasegawa, N; Ueki, N; Wakabayashi, M; Yamawaki, H | 1 |
2 trial(s) available for rabeprazole and z 338
| Article | Year |
|---|---|
Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.
Topics: Abdominal Pain; Acylation; Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Biomarkers; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Agents; Ghrelin; Humans; Japan; Male; Meals; Middle Aged; Postprandial Period; Prospective Studies; Rabeprazole; Thiazoles; Treatment Outcome; Young Adult | 2016 |
Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
Topics: Aged; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Surveys and Questionnaires; Thiazoles; Time Factors; Treatment Outcome | 2018 |
1 other study(ies) available for rabeprazole and z 338
| Article | Year |
|---|---|
Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities.
Topics: Abdominal Pain; Aged; Benzamides; Drug Therapy, Combination; Dyspepsia; Esters; Female; Gabexate; Gastrointestinal Agents; Guanidines; Humans; Male; Middle Aged; Pancreatitis, Chronic; Pancrelipase; Rabeprazole; Thiazoles; Treatment Outcome | 2019 |